{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT00411723: Phase 1 Interventional Unknown status Multiple Sclerosis, Chronic Progressive
(2006)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02957266: Phase 3 Interventional Unknown status Cervical Cancer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01373450: Phase 1 Interventional Completed Type 2 Diabetes Mellitus
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02652455: Early Phase 1 Interventional Completed Melanoma (Skin)
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03495427: Phase 2/Phase 3 Interventional Recruiting Prostate Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03014076: Phase 1 Interventional Completed Breastcancer
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00019682: Phase 3 Interventional Completed Recurrent Melanoma
(1999)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04432337: Not Applicable Interventional Withdrawn Inflammatory Response
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
USAN:VANDORTUZUMAB [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02598648: Not Applicable Interventional Recruiting Acute Respiratory Distress Syndrome
(2015)
Source URL:
Class:
PROTEIN
